Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT00696332 · COMPLETED
Trial details
- NCT number
- NCT00696332
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-04-01
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.